Linaclotide 290 micrograms
LIN-MD-31
Phase 3 small_molecule completed
Quick answer
Linaclotide 290 micrograms for Irritable Bowel Syndrome Characterized by Constipation is a Phase 3 program (small_molecule) at IRONWOOD PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IRONWOOD PHARMACEUTICALS INC
- Indication
- Irritable Bowel Syndrome Characterized by Constipation
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed